LISCure Biosciences
LISCure Biosciences is a biotech company. It has raised $26.0M across 2 rounds, most recently a $21.0M Series B in February 2021.
- Website
- liscure.bio
- Total Funding
- $26.0M
- Last Round
- $21.0M Series BFeb 2021
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
It has raised $26.0M in total across 2 rounds, most recently a $21.0M Series B round in Feb 2021. Investors include NHN Investment, Shinhan Investment and KB Securities.
Funding History
Feb 2021
Sign up to see all 2 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/liscure-biosciences"><img src="https://indexed.vc/api/badge/company/liscure-biosciences" alt="LISCure Biosciences on Indexed.vc" width="260" height="76" /></a>